中文别名:
乙基 4-甲基噻唑-5-羧酸酯;4-甲基-5-乙氧羰基噻唑;4-甲基噻唑-5-甲酸乙酯;4-甲基-5-噻唑甲酸乙酯;4-甲氧基-5-乙氧羰基噻唑;4-甲基噻唑-5-甲酸乙酯/4-METHYLTHIAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
英文名称:
Ethyl 4-methylthiazole-5-carboxylate
英文别名:
ETHYL 4-METHYLTHIAZOLE-5-CARBOXYLATE;ETHYL 4-METHYL-5-THIAZOLEACTATE;ETHYL 4-METHYL-5-THIAZOLYL FORMATE;5-THIAZOLECARBOXYLIC ACID, 4-METHYL-, ETHYL ESTER;Ethyl-4-methyl-5-thizaolecarboxylate;4-Methyl-5-Thiazolecarboxylic Acid Ethyl Ester;ETHYL 4-METHYL-5-THIAZOLECARBOXYLATE;ethyl 4-methyl-1,3-thiazole-5-carboxylate
InChI:
InChI=1/C8H11NO4S/c1-3-13-7(10)6-5(2)4-14-9(6)8(11)12/h4,6H,3H2,1-2H3,(H,11,12)
密度:
1.198±0.06 g/cm3(Predicted)
产品用途:
4-甲基噻唑-5-甲酸乙酯是合成头孢托仑匹酯(Cefditoren pivoxil)的关键中间体。头孢妥仑匹酯有日本明治制果公司研制,于 1994 年以Meiact 的商品名在日本上市。头孢妥仑匹酯对革兰阳性菌及革兰阴性菌具有广泛抗菌谱。